Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Grapevine Virus Screening Saves Napa-Sonoma $60M

Published: Tuesday, November 19, 2013
Last Updated: Tuesday, November 19, 2013
Bookmark and Share
Providing disease-free grapevines and rootstock to California’s famed North Coast wine region is money-wise to the tune of more than $60 million annually.

To quantify this benefit, the researchers developed an economic framework to conduct a case study of grapevine leafroll-3, the dominant grapevine virus in California and worldwide. They report their findings in a working paper released by the Center for Wine Economics at UC Davis’ Robert Mondavi Institute for Wine and Food Science. The complete paper is available online.

“This analysis places a dollar value on the efforts to prevent the spread of just a single disease in a single grape-growing region,” said Kate Binzen Fuller, the study’s lead author and a postdoctoral scholar in the Department of Agricultural and Resource Economics and Foundation Plant Services at UC Davis. “The overall benefits of such testing and certification are, in fact, dramatically higher,” she said.

Fuller added that the study revealed that the monetary benefits of such screening efforts far outweigh the costs related to screening and vine replacement.

“Even if growers have to pay a premium for certified, virus-free vines, this study suggests that they will receive a very large benefit. For the scenarios we evaluated, benefits are between six and 10 times the cost,” she said.

Viral threat to grapevines

Viruses and related disease-causing microbes pose a serious threat to agriculture because there are no effective controls available to growers, other than destroying infected plants. In the case of grapevines, viruses typically spread over long distances through the movement of infected plants or the use of infected cuttings and rootstock for propagating new plants.

Grapevine leafroll-3 appears in multiple strains, most causing leaves to redden and roll under along the edges. The disease diminishes fruit production and quality as grapes develop less pigmentation and sugar and mature more slowly. Growers have reported drops in yield of 30 percent and more; in some cases the disease even causes the plant graft to fail, killing the young vine.

The virus primarily is transmitted to the vine by mealybugs, tiny insects that are commonly found in California vineyards. Growers try to prevent grapevine leafroll-3 by testing their existing vines, using virus-free rootstocks and cuttings to grow new vines, removing diseased vines and spraying for mealybugs.

Screening plants for viruses

To prevent the introduction and spread of such viruses in grapevines, several clean-plant centers have been established throughout the United States, in partnership with the U.S. Department of Agriculture, to provide a large inventory of virus-screened plants to agricultural nurseries and growers.

In California, the Foundation Plant Services at UC Davis is responsible for screening and reproducing healthy, disease-free grapevines, as well as strawberries, fruit and nut trees, roses and sweet potatoes.

This meticulous process takes five to nine years and is costly, with expenses covered by revenue from plant sales to nurseries, several types of plant user fees, as well as custom contracts and virus testing.

Costs and benefits

The economic model created for this study by the UC Davis researchers compared the estimated value of losses incurred by North Coast winegrape growers due to grapevine leafroll disease with the estimated benefits realized by using vines that were certified to be virus-free. They did this by estimating what a grower’s net revenue would be in several different scenarios, based on initial disease appearance, disease spread, use of certified or noncertified vines, and replacement or nonreplacement of diseased vines.

“Results from applying this model indicate that, for the scenarios we examined, the most economically beneficial strategy is to plant initially with certified clean vines and to replace any vines that become diseased also with certified clean vines,” said study co-author Deborah Golino, a Cooperative Extension plant disease specialist and the director of Foundation Plant Services.

The researchers found that the average annual benefit to a grower from replacing diseased vines in a vineyard was 39 cents per vine or $512 per acre, if noncertified vines or rootstocks were used in both the initial and replacement plantings. The benefit for replanting diseased vines climbed to 55 cents per vine or $727 per acre if certified plant material was used to both plant and replant the vineyard.

Overall, the researchers estimate that, for just grapevine leafroll-3 virus, the vine certification program yields a benefit of between 30 cents and 47 cents per vine, or between $401 and $616 per acre. If all growers in the region were to use certified planting stock, this would translate to a benefit of between $40.4 and $61.8 million per year for the North Coast region. This benefit translates to between 4.8 percent and 7.4 percent of the wine grape revenue for that region.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Ultrafast DNA Diagnostics
New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
Monday, August 03, 2015
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Simple Technology Makes CRISPR Gene Editing Cheaper
University of California, Berkeley, researchers have discovered a much cheaper and easier way to target a hot new gene editing tool, CRISPR-Cas9, to cut or label DNA.
Friday, July 24, 2015
Printed "Smart Cap" Detects Spoiled Food
It might not be long before consumers can just hit “print” to create an electronic circuit or wireless sensor in the comfort of their homes.
Tuesday, July 21, 2015
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
Friday, July 03, 2015
Delivering Drugs to the Right Place
Thomas Weimbs has developed a targeted drug delivery method that could potentially slow the progression of polycystic kidney disease.
Monday, June 29, 2015
The Deep Carbon Cycle
Over billions of years, the total carbon content of the outer part of the Earth—in its upper mantle, crust, oceans and atmospheres—has gradually increased, scientists report.
Tuesday, June 23, 2015
Designing New Pain Relief Drugs
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain.
Thursday, June 11, 2015
Engineers Crack DNA Code of Autoimmune Disorders
Researchers have identified an unexpectedly general set of rules that determine which molecules can cause the immune system to become vulnerable to the autoimmune disorders lupus and psoriasis.
Wednesday, June 10, 2015
Genetic Markers for Detecting and Treating Ovarian Cancer
Custom bioinformatics algorithm identifies human mRNAs that distinguish ovarian cancer cells from normal cells and provide new therapeutic targets
Wednesday, May 27, 2015
Researchers Reverse Bacterial Resistance to Antibiotics
Evidence continues to surface that supports the premise that antibiotics which have been out of use could still be effective in treating drug-resistant bacteria.
Friday, May 08, 2015
Industry-Sponsored Academic Inventions Spur Increased Innovation
Analysis questions assumption that corporate support skews science toward inventions that are less useful than those funded by the government or non-profit organizations.
Monday, March 24, 2014
May the Cellular Force be With You
Like tiny construction workers, cells sculpt embryonic tissues and organs in 3D space.
Friday, December 13, 2013
Grant Supports Creation of Patient-Derived Stem Cell Lines
Researchers have received a two-year, $600,000 grant from the National Institute on Aging to develop and study patient-derived stem cell lines.
Thursday, December 12, 2013
Prostate Cancer Stem Cells are a Moving Target
Researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.
Friday, December 06, 2013
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!